RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 115 filers reported holding RELAY THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,917 | -27.7% | 5,222 | +7.9% | 0.00% | -33.3% |
| Q2 2023 | $60,765 | -23.7% | 4,838 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $79,682 | +1.3% | 4,838 | -8.1% | 0.00% | 0.0% |
| Q4 2022 | $78,644 | -22.9% | 5,264 | +15.5% | 0.00% | -20.0% |
| Q3 2022 | $101,962 | +33.6% | 4,558 | 0.0% | 0.01% | +66.7% |
| Q2 2022 | $76,347 | -44.0% | 4,558 | 0.0% | 0.00% | -40.0% |
| Q1 2022 | $136,421 | -75.4% | 4,558 | -74.8% | 0.01% | -37.5% |
| Q4 2021 | $555,667 | +8.2% | 18,094 | +11.1% | 0.01% | +14.3% |
| Q3 2021 | $513,435 | -13.8% | 16,284 | 0.0% | 0.01% | -12.5% |
| Q2 2021 | $595,832 | +34.3% | 16,284 | +26.9% | 0.01% | +14.3% |
| Q1 2021 | $443,568 | +13.2% | 12,831 | +36.1% | 0.01% | +16.7% |
| Q4 2020 | $391,703 | -2.4% | 9,425 | 0.0% | 0.01% | -14.3% |
| Q3 2020 | $401,411 | – | 9,425 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |